| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $2.75B | +16.2% |
| Cost of Revenue | $699.6M | +3.3% |
| Gross Profit | $2.05B | +21.4% |
| R&D Expense | $693.1M | +10.2% |
| SG&A Expense | $265.7M | +7.8% |
| Operating Income | $691.4M | +61.0% |
| Pre-tax Income | $919.4M | +56.4% |
| Income Tax | $205.2M | +229.3% |
| Net Income | $714.1M |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.12B | +59.0% |
| Accounts Receivable | $1.02B | +19.3% |
| Current Assets | $6.31B | +26.1% |
| Total Assets | $7.34B | +24.2% |
| Current Liabilities | $1.40B | +18.6% |
| Total Liabilities | $1.51B | +19.1% |
| Stockholders' Equity | $5.83B | +25.6% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.09B | +19.6% |
| Investing Cash Flow | -$700.1M | +35.0% |
| Financing Cash Flow | $26.1M | +261.3% |
| +35.8% |
| EPS (Basic) | $4.41 | +34.9% |
| EPS (Diluted) | $4.32 | +34.2% |